http://www.PROACTIVEcme.org en-us PROACTIVEcme.org - The France Foundation PROACTIVE (PROstAte Cancer ETIology: Approaching PreVention through Education) is a national continuing medical education curriculum designed to provide urologists, internists, and family practitioners with practice improvements in the prevention of prostate cancer. PROACTIVE-cme.org Peer-to-Peer Podcast Series features insightful, in-depth audio commentary from a prestigious group of prostate cancer experts. Listen in for state-of-the-art information as they address timely, clinically relevant topics identified by the expert faculty. The France Foundation mpereira@francefoundation.com Copyright 2009 The France Foundation Tuesday, 1 September 2009 03:01:00 EST Thu, 8 Oct 2009 60 PROACTIVE-cme.org http://www.PROACTIVE-cme.org/podcast/PROACTIVEcme_Session_03.mp3 What are the important results from prostate cancer chemoprevention clinical trials, including the Prostate Cancer Prevention Trial (PCPT), REDUCE, and SELECT trials? Demonstrate familiarity with current evidence assessing prostate cancer prevention strategies, including chemoprevention with pharmacologic agents. CME Peer-to-Peer Dialogue Thu, 19 Nov 2009 03:06:00 EDT 00:13:14 Prostate, Cancer, PSA, CME, CME Credit, Pharmacist, CE, Primary, Care, Nurses, Prevention PROACTIVE-cme.org http://www.PROACTIVE-cme.org/podcast/PROACTIVEcme_Session_02.mp3 Prostate cancer mortality results from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial and the European Randomized Study of Screening for Prostate Cancer were published earlier this year in the New England Journal of Medicine. What were the significant findings of these studies? What are the current guidelines on screening for prostate cancer? What are the controversies? Recognize the differences, strengths, and limitations of current prostate cancer screening tests and discuss the rationale and appropriate use of clinical guidelines in screening for prostate cancer. CME Peer-to-Peer Dialogue Thu, 8 Oct 2009 03:06:00 EDT 00:12:37 Prostate, Cancer, PSA, CME, CME Credit, Pharmacist, CE, Primary, Care, Nurses, Prevention PROACTIVE-cme.org http://www.PROACTIVE-cme.org/podcast/PROACTIVEcme_Session_01.mp3 What are the risk factors for prostate cancer? How do these risk factors impact counseling strategies with patients? What are the strengths and limitations of current prostate screening tests? Explain the difference between free prostate specific antigen (PSA), PSA velocity, and the ratio of bound to free PSA. Describe individualized patient risk factors for prostate cancer and how to incorporate this information into an overall assessment and counseling strategy with patients. Recognize the differences, strengths, and limitations of current prostate cancer screening tests. CME Peer-to-Peer Dialogue Tue, 1 Sep 2009 03:06:00 EDT 00:23:37 Prostate, Cancer, PSA, CME, CME Credit, Pharmacist, CE, Primary, Care, Nurses, Prevention